Perbedaan Indofarma Tbk. dan Bank Multiarta Sentosa Tbk.: Indofarma Tbk. diperdagangkan di Rp126 (kapitalisasi pasar 390,51 M), sedangkan Bank Multiarta Sentosa Tbk. diperdagangkan di Rp3.360 (kapitalisasi pasar 4,7 T, volume 24 jam 10 rb). Perbedaan utamanya: Bank Multiarta Sentosa Tbk. jauh lebih besar — sekitar 12× kapitalisasi pasar Indofarma Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| INAF | MASB | |
|---|---|---|
Kapitalisasi Pasar | 390,51 M | 4,7 T |
Volume | — | 10 rb |
Lot | — | 100 |
Perputaran | — | 33,47 jt |
Harga Rata-rata | — | 3.347 |
Nilai Transaksi | — | 33,47 jt |
Harga Ekuilibrium Indikatif | — | 3.230 |
Volume Ekuilibrium Indikatif | — | 10 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk (the Company) was established based on Deed No. 1 dated January 2, 1996 as amended by Deed No. 134 dated January 26, 1996 both of Notary Sutjipto, SH. PT. Indofarma, Tbk began as medicine factory well known as "Pabrik Obat Manggarai". Then take over by Japan's Government from Nederland's Government on 1942. On 1950 the Indonesian Government acquisited the factory by Department of Health and functioned as center of pharmacy production for its department. On 1979 the name changed to be Department of Health Center of Pharmacy Production as non Profit institution as main assignment to produced medicine for public service. Then the Company changed the name as PT. Indonesia Farma Tbk, known as PT Indofarma (Persero) Tbk.
Selengkapnya di halaman INAF →PT Bank Multiarta Sentosa Tbk (the Bank) was established by Deed No.201 dated July 28, 1992 of H.Saidus Sjahar, S.H. The Bank's parent company is PT Danabina Sentana which is the majority stockholder of the Bank. The majority shareholder of PT Danabina Sentana is PT Lumbung Artakencana which is a company established in Indonesia and the Bank’s ultimate shareholder that joined in business group of Wings Group.
Selengkapnya di halaman MASB →